相关实验视频
Updated: Jul 24, 2025
08:18
Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
3.4K
尼菲迪平对阿尔多减少酶的抑制作用延迟了白内障的进展
Alaparthi Malini Devi1, Venu Sankeshi1, Arugonda Ravali1
1Drug Design & Molecular Medicine Laboratory, Department of Genetics & Biotechnology, Osmania University, Hyderabad, 500007, India.
Naunyn-Schmiedeberg's archives of pharmacology
|July 3, 2023
概括
尼菲迪平有效抑制阿尔多减少酶 (ALR2),这是糖尿病白内障形成的关键酶. 这种化合物减少了氧化应激,并保持了透镜功能,为糖尿病眼病提供了潜在的治疗方法.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 眼科医生 眼科 眼科
背景情况:
- 阿尔多减少酶 (ALR2) 是聚醇通路中的关键酶,通过氧化应激和改变平衡,涉及糖尿病白内障.
- 现有的ALR2抑制剂往往缺乏足够的灵敏度和特异性,凸显了对新型治疗剂的需求.
- 糖尿病白内障是老年人视力受损的重要原因,需要针对高糖症的有效治疗.
研究的目的:
- 调查尼菲迪平的抑制潜力,一个二尼古丁胺类类似物,对阿尔多减酶 (ALR2) 活性.
- 在体内评估nifedipine在改善糖尿病白内障进展方面的疗效.
- 在糖尿病老鼠模型中评估尼菲迪平对氧化应激标记物和透镜蛋白功能的影响.
主要方法:
- 酶抑制试验使用纯化复合人体阿尔多减少酶 (hAR).
- 试验室生物分子相互作用研究,包括异热定位热量计 (ITC) 和光火试验.
- 在体内验证在链毒素 (STZ) 诱导的糖尿病大鼠模型中,以评估白内障进展和生化标志物.
主要成果:
- 尼菲迪平对hAR具有显著的抑制潜力,IC50为2.5μM,并显示结合亲和力 (Kd = 2.91 × 10−4 M).
- 在体内研究表明,尼费迪平在糖尿病大鼠中延迟了白内障的发病和进展.
- 尼菲迪平通过降低眼内水平,保留了抗氧化酶活性,减少了氧化应激标志物,并保持了α-晶伴侣活性.
结论:
- 尼菲迪平有效抑制阿尔多减少酶 (ALR2),减轻糖尿病白内障的关键病理特征.
- 该化合物减少了氧化和透应激,同时保持了透镜中的α-晶体的关键伴侣功能.
- 尼菲迪平为改善糖尿病并发症患者眼睛健康提供了一个有前途的治疗策略.
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
698
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
698
01:25Antihypertensive Drugs: Direct Renin Inhibitors
699
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
699
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
572
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
572
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
01:27Phase I Reactions: Reductive Reactions
229
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
229
01:16Antianginal Drugs: Nitrates and β-Blockers
656
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
656